Abstract:
The present invention relates to monoterpenoid and phenylpropanoid containing derivative compounds, methods of making the compounds, compositions comprising the compounds, and methods of repelling pests using the compounds and/or compositions.
Abstract:
One aspect of the present invention is a polyoxyalkylene ester composition comprising the reaction product of a polyoxyalkylated alcohol or polyol reactant and an acyl donor wherein the ester has greater than about 85 weight percent of a fully acylated polyoxyalkylene ester, less than about 15 percent of a partially acylated polyoxyalkylene ester, less than about 5 parts per million 1,4-dioxane and an acid number of less than about 20. Another aspect of the invention is a process for making the polyoxyalkylene ester composition that includes the steps of contacting a reaction mixture of an polyoxyalkylated alcohol or polyol reactant and an acyl donor reactant in a reactor and in the presence of an enzymatic catalyst under esterification conditions and recovering the polyoxyalkylene ester.
Abstract:
La présente invention se rapporte à l'utilisation d'ester(s) d'acide(s) gras, en particulier du dodécanoate de 3-méthylbutyle, ou d'un mélange d'esters d'acides gras, comme insecticide et/ou arachnicide, et à des compositions insecticides et/ou arachnicides les comportant. Elle vise également un procédé de lutte contre les insectes et/ou les arachnides.
Abstract:
The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders — including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders — using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
Abstract:
A process for producing an ester which comprises: a step in which an alcohol is reacted with a carboxylic acid to obtain a crude esterification product; and a step in which 5 to 100 parts by weight of a hydrocarbon solvent is added to 100 parts by weight of the crude esterification product and the resultant mixture is deacidified with an aqueous alkali solution. An alcohol solvent can be further added according to need. The process enables a high-quality ester to be obtained in high yield.
Abstract:
본 발명은 지방산 함유 유지로부터 지방산 메틸 에스테르를 제조하는 데에 사용되는 고체 촉매를 상기 지방산 함유 유지를 함유하는 전처리액에 침지시키는 것을 포함하는, 지방산 메틸 에스테르 제조용 고체 촉매의 활성화 방법, 및 상기 방법으로 활성화한 고체 촉매를 이용하여 회분식 공정으로 지방산 메틸 에스테르를 수득하는 것을 포함하는, 지방산 메틸 에스테르의 제조 방법에 관한 것이다.
Abstract:
AlkyI esters (butyl, hexyl, or other) of full composition palm fatty acids, palm fatty acid distillates (PFAD), and palm kernel fatty acid distillates (PKFAD) can be used to generate polyurethane and lubricant products. The alkyl esters of the present invention can be produced via ozonolysis. The improved method for producing alkyl esters includes reacting at least one substance having at least one carbon-to-carbon double bond with ozone in the presence of least one monoalcohol that azeotropes with water. In particular, the method may comprise reacting with at least one first mole of ozone and at least one second mole of ozone, and further comprises refluxing before addition of the second mole of ozone.
Abstract:
Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R 1 is a linear or branched C 9 -C 33 alkyl or a linear or branched C 9 -C 33 alkenyl with 1 to 4 double bonds; R 2 is a linear or branched C 9 -C 19 alkyl or a linear or branched C 9 -C 19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.
Abstract:
The present invention relates to 1,3-dioxoindene derivatives, pharmaceutically acceptable salts or optical isomers thereof, a preparation method for same, and a pharmaceutical composition containing same as an active ingredient with antiviral activity. The 1,3-dioxoindene derivatives of formula (1) according to the present invention have low cyto-toxicity, and can also demonstrate utility as pharmaceutical compositions for preventing or treating viral diseases such as: polio, viral paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-mouth disease, blistering diseases, hepatitis A, myositis, myocarditis, pancreatitis, viral diabetes, epidemic myalgia, encephalitis, flu, herpes angina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis, otitis media, and the like, since excellent antiviral activity against picornaviruses such as Coxsackie virus, enterovirus, echovirus, polio virus, rhinovirus, and the like, have been demonstrated.
Abstract:
Vorgeschlagen wird ein Verfahren zur kontinuierlichen Veresterung von C1-C22-(Fett)säuren mit C1-C10-Monoalkanolen, C2-C5- Di- bzw. Trialkanolen, oder Mischungen hiervon, in flüssiger Phase im Gegenstromverfahren, in Gegenwart von heterogenen Katalysatoren im Vorreaktor (1) und in der Reaktionskolonne (3), dadurch gekennzeichnet, dass ein Vorreaktor (1) und eine Abtrenneinheit (2) der Reaktionskolonne (3) zur Verringerung der Viskosität des Reaktionsgemisches vorgeschalte wird und über die Abtrenneinheit (2), zur Verschiebung des Reaktionsgleichgewichts vor der Reaktionskolonne (3) das Reaktionswasser aus dem System entfernt wird.